The Reactive Skin Decontamination Lotion (RSDL) is a Joint Program consisting of decontaminant(s) and applicator(s) required to immediately reduce morbidity and mortality resulting from Chemical, Biological, Radiological, and Nuclear (CBRN) contamination of the skin.
RSDL is a topical decontamination solution that has been tested and shown to reduce toxic effects from exposure to chemical warfare agents (VX and HD) and T-2 toxin. RSDL contains Dekon 139 and a small amount of 2,3 butadiene monoxime (DAM). These compounds are dissolved in a solvent composed of polyethylene glycol monomethyl ether (MPEG) and water. This solvent system is particularly important as it promotes the decontamination reaction by actively desorbing, retaining and sequestering the chemical agent, while the active ingredient (Dekon 139) chemically reacts with, and rapidly neutralizes the vesicant chemical or the organophosphorous nerve agent.This reaction starts immediately and neutralization is usually complete within two minutes.
RSDL is a patented, broad spectrum topical skin decontamination product intended to neutralize or remove CW
agents and T-2 toxin from the skin.
• GA (TABUN)
• GB (SARIN)
• GD (SOMAN)
• GF (Cyclohexyl SARIN)
• VX (Nerve Agent)
• HD (Mustard)
• T-2 toxin
RSDLwas originally developed by the Canadian Department of National Defence (DND), RSDL has since been adopted by several military services around the world. The U.S. FDA issued 510(k) clearance for RSDL in March of 2003 and has cleared the use of RSDL in 21 and 42 mL packets.